Literature DB >> 16551485

Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.

Julie Minet-Ringuet1, Patrick C Even, Marc Goubern, Daniel Tomé, Renaud de Beaurepaire.   

Abstract

Body weight gain is a worrying side effect of many new antipsychotic drugs. The mechanisms by which antipsychotic drugs increase weight in humans are not known. Attempts to model the metabolic effects of antipsychotic drugs in the animal have not been successful. Female rats appear to be sensitive to the effects of antipsychotics, but male rats less, and this does not match the clinical situation in humans. In previous rodent studies, antipsychotics were always given by daily gavage or injections. Antipsychotics have different pharmacokinetics in rodents and humans, and in the present study, we tested the hypothesis that the insensitivity of male rats to the effects of antipsychotics could be related to their mode of administration. Thus, we administered antipsychotic drugs mixed with the food. Animals were treated during 6 weeks with haloperidol (1mg/kg), olanzapine (1mg/kg), ziprasidone (10mg/kg), or a control solution. Animals were allowed to self-select food among three macronutrients (carbohydrates, lipids and proteins). Food selection was measured throughout the study. At the end of the study, body composition was measured by dissection and weighing of the rat's main organs and tissues. Mitochondrial thermogenesis was measured in brown adipose tissue in olanzapine-treated animals. Circulating leptin, insulin, glucose, triglycerides, cholesterol, high-density lipoprotein (HDL) were also assayed at the end of the study. The results show that none of the antipsychotic treatments modified caloric intake, food selection or body weight. Olanzapine did not alter mitochondrial thermogenesis. However, haloperidol and olanzapine induced a significant increase in adiposity and circulating leptin. Ziprasidone produced a moderate fat accumulation. It is concluded that mixing antipsychotic treatments with the food provides a reliable animal model of antipsychotic-induced fat accumulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551485     DOI: 10.1016/j.appet.2006.01.008

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  23 in total

1.  Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.

Authors:  Elodie M Girault; Bruno Guigas; Anneke Alkemade; Ewout Foppen; Mariëtte T Ackermans; Susanne E la Fleur; Eric Fliers; Andries Kalsbeek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-05       Impact factor: 3.000

2.  Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats.

Authors:  Martina von Wilmsdorff; Fabian Manthey; Marie-Luise Bouvier; Oliver Staehlin; Peter Falkai; Eva Meisenzahl-Lechner; Andrea Schmitt; Peter J Gebicke-Haerter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-05       Impact factor: 5.270

3.  A model for antipsychotic-induced obesity in the male rat.

Authors:  Julie Minet-Ringuet; Patrick C Even; Magali Lacroix; Daniel Tomé; Renaud de Beaurepaire
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

4.  Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters.

Authors:  Kieran J Davey; Siobhain M O'Mahony; Harriet Schellekens; Orla O'Sullivan; John Bienenstock; Paul D Cotter; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2012-01-11       Impact factor: 4.530

5.  Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.

Authors:  SuJean Choi; Briana DiSilvio; JayLynn Unangst; John D Fernstrom
Journal:  Life Sci       Date:  2007-08-17       Impact factor: 5.037

6.  Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis.

Authors:  V L Albaugh; J G Judson; P She; C H Lang; K P Maresca; J L Joyal; C J Lynch
Journal:  Mol Psychiatry       Date:  2010-03-23       Impact factor: 15.992

7.  The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.

Authors:  Martina von Wilmsdorff; Marie-Luise Bouvier; Uwe Henning; Andrea Schmitt; Wolfgang Gaebel
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

8.  Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats.

Authors:  Montserrat Victoriano; Dominique Hermier; Patrick C Even; Gilles Fromentin; Jean-François Huneau; Daniel Tomé; Renaud de Beaurepaire
Journal:  Psychopharmacology (Berl)       Date:  2009-07-02       Impact factor: 4.530

9.  Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors.

Authors:  Shona L Kirk; John Glazebrook; Ben Grayson; Joanna C Neill; Gavin P Reynolds
Journal:  Psychopharmacology (Berl)       Date:  2009-08-18       Impact factor: 4.530

Review 10.  Atypical antipsychotics and effects on feeding: from mice to men.

Authors:  Louise Benarroch; Chantel Kowalchuk; Virginia Wilson; Celine Teo; Melanie Guenette; Araba Chintoh; Yasika Nesarajah; Valerie Taylor; Peter Selby; Paul Fletcher; Gary J Remington; Margaret K Hahn
Journal:  Psychopharmacology (Berl)       Date:  2016-06-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.